Loading...
11 Russia Device Drug Combination Reports
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Roche, Medtronics, Novo Nordisk, Eli Lilly, Sanofi
Country Covered: Russia
Study Period: 2019- 2029
Major Players: Abbott Diabetes Care, Medtronic PLC, Novo Nordisk A/S, Roche Diabetes Care, Lifescan Inc.
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Medtronics, Roche, NovoNordisk, Sanofi, Omnipod
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Roche Diabetes Care, Medtronic PLC, Novo Nordisk A/S, Dexcom Inc., Abbott
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Eli Lilly, Biocon, Sanofi, Medtronic
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Eli Lilly and Company, Medtronic PLC, Sanofi Aventis, Becton Dickinson and Company, Novo Nordisk A/S
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Novo Nordisk A/S, Medtronic, Dexcom Inc., Abbott Diabetes Care, Roche Diabetes Care
Country Covered: Russia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Julphar
Country Covered: Russia
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Sanofi, El lilly, Medtronics, Roche
Country Covered: Russia
Study Period: 2018-2029
Major Players: Abbott, Medtronic, Lilly, Novo Nordisk, Roche